JPMorgan Chase & Co’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Buy |
39,397
+38,556
| +4,585% | +$1.82M | ﹤0.01% | 3387 |
|
|
2025
Q1 | $32.9K | Sell |
841
-409
| -33% | -$16K | ﹤0.01% | 5154 |
|
|
2024
Q4 | $67.7K | Buy |
1,250
+14
| +1% | +$758 | ﹤0.01% | 4912 |
|
|
2024
Q3 | $62.3K | Sell |
1,236
-16,472
| -93% | -$831K | ﹤0.01% | 4917 |
|
|
2024
Q2 | $779K | Buy |
17,708
+17,703
| +354,060% | +$778K | ﹤0.01% | 3636 |
|
|
2024
Q1 | $251 | Sell |
5
-1,443
| -100% | -$72.4K | ﹤0.01% | 5773 |
|
|
2023
Q4 | $87.4K | Sell |
1,448
-274,150
| -99% | -$16.6M | ﹤0.01% | 4831 |
|
|
2023
Q3 | $15.7M | Sell |
275,598
-22,580
| -8% | -$1.29M | ﹤0.01% | 1667 |
|
|
2023
Q2 | $15.2M | Sell |
298,178
-5,044
| -2% | -$257K | ﹤0.01% | 1728 |
|
|
2023
Q1 | $6.49M | Buy |
303,222
+258,378
| +576% | +$5.53M | ﹤0.01% | 2280 |
|
|
2022
Q4 | $471K | Buy |
+44,844
| New | +$471K | ﹤0.01% | 3793 |
|